keyword
https://read.qxmd.com/read/37641997/balance-impairment-in-patients-with-rheumatoid-arthritis-and-ankylosing-spondylitis
#21
JOURNAL ARTICLE
Ali Erman Kent, Emre Gürses, Figen Karabekiroğlu, Aydan Genç
BACKGROUND: Balance weaknesses related to mobility and fall risk in patients with rheumatic diseases are well-known. Vestibular dysfunction could negatively contribute to the balance ability of this patient population. This study aims to investigate the effects of Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS), among the most common rheumatic diseases, on postural balance related to vestibular function. METHODS: Seventy-eight participants were grouped as RA (n=34, 43%), AS (n=24, 30...
August 28, 2023: Current Rheumatology Reviews
https://read.qxmd.com/read/37612889/costovertebral-and-costotransverse-joint-involvement-in-spondyloarthritis
#22
JOURNAL ARTICLE
Emine Büşra Ata, Gamze Durhan, Emre Bilgin, Orhan Macit Arıyürek, Umut Kalyoncu
OBJECTIVES: Costovertebral (CV), costotransverse (CTr), sternoclavicular (SC), and manubriosternal (MS) joints are impacted in spondyloarthritis (SpA) patients; however, clinical aspects of these involvements require additional evaluation. METHODS: A total of 281 SpA patients who had undergone chest computed tomography (CT) for any reason between 2010 and 2020 were included in the study. SpA patients were divided into three groups, ankylosing spondylitis (AS), non-radiographic axial SpA, and psoriatic arthritis...
August 23, 2023: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/37568031/clinical-and-economic-benefit-of-advanced-therapies-for-the-treatment-of-active-ankylosing-spondylitis
#23
JOURNAL ARTICLE
Jessica A Walsh, Christopher D Saffore, Eric B Collins, Andrew Ostor
INTRODUCTION: Recent changes to treatment guidelines for ankylosing spondylitis (AS) have listed first-line advanced therapies as tumor necrosis factor (TNF), interleukin (IL)-17, and Janus kinase (JAK) inhibitors. This study sought to assess the comparative clinical and economic benefit of advanced therapies approved for AS. METHODS: A systematic literature review was conducted to identify randomized clinical trials for JAK inhibitors (upadacitinib [UPA], tofacitinib [TOF]), anti-IL-17 therapies (secukinumab [SEC], ixekizumab [IXE]), and TNF inhibitors (adalimumab [ADA], etanercept [ETN], golimumab [GOL]) used for the treatment of active AS...
October 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37451619/severe-disseminated-infection-by-hypermucoviscous-klebsiella-pneumoniae-successfully-treated-by-intensive-therapy-with-continuous-hemodiafiltration-using-an69st-a-case-report-and-review-of-the-literature
#24
Kazuhiro Tada, Ryoko Shibata, Tsubasa Nakamura, Yoshihiro Kawaguchi, Yuki Nakano, Hidehiro Ishii, Kazuya Ura, Hiroyoshi Yamada, Shinichi Maekawa, Kenji Ito, Kosuke Masutani
Klebsiella pneumoniae (Kpn) is one of the most common gram-negative bacilli causing lung, urinary tract, and biliary tract infections. However, as a distinct entity from classic Kpn, hypervirulent Kpn causing liver abscess, endophthalmitis, and lung abscess with poor prognoses has been reported mainly in East and Southeast Asia since the mid-1980s. Although the definition of hypervirulent Kpn is unclear, the hypermucoviscosity of Kpn is considered an important feature of hypervirulence. We present a case of emphysematous pyelonephritis accompanied by septic shock and acute kidney injury caused by hypermucoviscous Kpn infection that was successfully treated by intensive treatment...
July 12, 2023: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/37393989/mono-segmental-percutaneous-screw-fixation-in-the-management-of-aospine-thoracolumbar-type-b-fracture-in-patients-with-ankylosing-spondylitis-a-new-treatment
#25
JOURNAL ARTICLE
D Masson, I Mezjan, P-H Pretat, S Colnat-Coulbois, T Civit, N Mansouri
PURPOSE: To assess the viability and effectiveness of mono-segmental percutaneous screw fixation in the treatment of unstable type B thoracolumbar fracture due to ankylosing spondylitis. METHODS: We report here all 40 patients treated by mono-segmental screw fixation in this indication, between January 2018 and January 2022, with follow-up at 3 and 9 months. Study variables comprised operating time, length of stay, fusion, stabilization quality, and peri-operative morbidity and mortality...
June 30, 2023: Neuro-Chirurgie
https://read.qxmd.com/read/37351781/pain-and-inflammation-as-mediators-of-tofacitinib-treatment-effect-on-fatigue-in-patients-with-ankylosing-spondylitis-a-mediation-analysis
#26
JOURNAL ARTICLE
Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, Andrew G Bushmakin, Joseph C Cappelleri, Arne Yndestad, Oluwaseyi Dina, Peter C Taylor
INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for treatment of ankylosing spondylitis (AS). Using mediation modelling, we describe interrelationships between fatigue, pain, morning stiffness, C-reactive protein (CRP) and tofacitinib treatment in patients with AS. METHODS: Data from phase 2 (NCT01786668)/phase 3 (NCT03502616) studies of patients receiving tofacitinib 5 mg twice daily (BID) or placebo were used. Initial models included treatment as the independent binary variable (tofacitinib 5 mg BID versus placebo); fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue [FACIT-F; model A] or Bath AS Disease Activity Index [BASDAI] Q1 [model B]) as the dependent variable; and pain (total back pain/nocturnal spinal pain [model A] or pain measured by BASDAI Q2/3 [model B]), morning stiffness (BASDAI Q5/6) and CRP as mediator variables...
June 23, 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37331992/tofacitinib-reduces-spinal-inflammation-in-vertebral-bodies-and-posterolateral-elements-in-ankylosing-spondylitis-results-from-a-phase-2-trial
#27
JOURNAL ARTICLE
Mikkel Østergaard, Joseph Wu, Lara Fallon, Sarah P Sherlock, Cunshan Wang, Dona Fleishaker, Keith S Kanik, Walter P Maksymowych
INTRODUCTION: This post hoc analysis of phase 2 trial data assessed the efficacy of tofacitinib on magnetic resonance imaging (MRI) outcomes with the detailed anatomy-based Canada-Denmark (CANDEN) MRI scoring system and evaluated tofacitinib suppression of spinal inflammation in patients with active ankylosing spondylitis (AS). METHODS: Patients with active AS (per modified New York criteria) were randomized 1:1:1:1 to receive tofacitinib 2, 5, or 10 mg twice daily (BID), or placebo, in a 16-week, phase 2, double-blind clinical trial...
June 18, 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37322274/effect-of-intravenous-golimumab-on-fatigue-and-the-relationship-with-clinical-response-in-adults-with-active-ankylosing-spondylitis-in-the-phase-3-go-alive-study
#28
JOURNAL ARTICLE
Atul Deodhar, Natalie J Shiff, Cinty Gong, Eric K H Chan, Elizabeth C Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D Reveille
INTRODUCTION: We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in adults with active ankylosing spondylitis (AS) in the GO-ALIVE trial. METHODS: Patients were randomized to IV-golimumab 2 mg/kg (N = 105) at week (W) 0, W4, then every 8 W (Q8W) or placebo (N = 103) at W0, W4, W12, crossover to IV-golimumab 2 mg/kg at W16, W20, then Q8W through W52...
June 15, 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37191738/effect-of-upadacitinib-on-quality-of-life-and-work-productivity-in-active-non-radiographic-axial-spondyloarthritis-results-from-randomized-phase-3-trial-select-axis-2
#29
JOURNAL ARTICLE
Uta Kiltz, Mitsumasa Kishimoto, Jessica A Walsh, Percival Sampaio-Barros, Manish Mittal, Christopher D Saffore, Peter Wung, Fabiana Ganz, Ana Biljan, Denis Poddubnyy
INTRODUCTION: To evaluate the effect of upadacitinib vs. placebo on health-related quality of life (HRQoL) and work productivity in patients with active non-radiographic axial spondyloarthritis (nr-axSpA) enrolled in the SELECT-AXIS 2 phase 3 randomized controlled trial. METHODS: Adult patients with active nr-axSpA and an inadequate response to non-steroidal anti-inflammatory drugs were randomized 1:1 to receive upadacitinib 15 mg once daily or placebo. Mean changes from baseline in measures of HRQoL (Ankylosing Spondylitis QoL [ASQoL], Assessment of SpondyloArthritis international Society Health Index [ASAS HI], Short-Form 36 Physical Component Summary [SF-36 PCS] score) and Work Productivity and Activity Impairment (WPAI) were assessed through 14 weeks based on mixed-effects repeated measures or analysis of covariance models...
May 16, 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37181194/ankylosing-spondylitis-masquerading-as-generalized-spasticity-in-a-patient-with-spinal-cord-injury-in-neurological-rehabilitation-setting-a-case-report
#30
Gourav Sannyasi, Meeka Khanna, Anupam Gupta, Navin Prakash
A thorough history and examination in rehabilitation settings are paramount. We present a case of spinal cord injury with quadriparesis with severe axial stiffness and increasing spasticity not responding to high doses of medication. Only after repeated inquiry, patient gave history of symptoms suggestive of ankylosing spondylitis (AS). Initiating treatment for AS resulted in decreased stiffness and spasticity and improved functional outcome in the patient.
2023: Journal of Neurosciences in Rural Practice
https://read.qxmd.com/read/36945163/trajectory-of-anxiety-depression-and-quality-of-life-in-ankylosing-spondylitis-a-descriptive-study
#31
JOURNAL ARTICLE
Bilinc Dogruoz Karatekin, Afitap Icagasioglu, Fusun Moral Oguz, Seyma Nur Bayindir, Ozge Pasin
OBJECTIVE: To investigate anxiety, depression, and health-related quality of life (HRQoL) over 15 years and associations between demographic, disease-related variables, anxiety and depression, and HRQoL in patients with AS. STUDY DESIGN: Descriptive study. Place and Duration of the Study: Istanbul Medeniyet University Goztepe Prof. Dr. Suleymsan Yalcin City Hospital, from June to December 2021. METHODOLOGY: Seventy-five patients with AS, who were followed up in Physical Medicine and Rehabilitation outpatient clinic for 15 years, were included in this study, after their diagnosis was confirmed by the hospital system...
March 2023: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/36875965/rapidly-progressing-dysphagia-after-thoracic-spinal-cord-injury-in-a-patient-with-ankylosing-spondylitis-a-case-report
#32
Beom Su Kim, So Young Lee, Jun Hwan Choi, Mina Seok, Su Yeon Ko, Hyun Jung Lee
INTRODUCTION: Ankylosing spondylitis (AS) is a chronic systemic inflammatory disease affecting the axial skeleton, including the sacroiliac joint, which causes vertebral fusion in the advanced stage. However, reports of anterior cervical osteophytes compressing the esophagus and causing dysphagia in patients with AS are rare. Here, we present the case of a patient with AS and anterior cervical osteophytes who exhibited rapidly progressing dysphagia after thoracic spinal cord injury (SCI)...
2023: Geriatric Orthopaedic Surgery & Rehabilitation
https://read.qxmd.com/read/36820984/effect-of-upadacitinib-on-disease-activity-pain-fatigue-function-health-related-quality-of-life-and-work-productivity-for-biologic-refractory-ankylosing-spondylitis
#33
JOURNAL ARTICLE
Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar
INTRODUCTION: Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvement in patient-reported outcomes (PROs) assessing disease activity, pain, fatigue, function, health-related quality of life (HRQoL), and work productivity in patients with AS with inadequate responses or intolerance to biologic disease-modifying antirheumatic drugs (bDMARD-IR)...
February 23, 2023: Rheumatology and Therapy
https://read.qxmd.com/read/36819453/physiotherapy-rehabilitation-of-a-conservatively-managed-patient-with-pott-s-disease-a-case-report
#34
Komal S Mandhane, Pratik Phansopkar, Neha V Chitale
The granulomatous disease tuberculosis (TB) is brought on by the bacteria Mycobacterium tuberculosis . Skeletal TB is involved in 10-35% of extra-pulmonary reported cases worldwide, with the most common kind being tuberculous spondylitis (Pott's disease). Depending upon the extent of spinal engagement, the clinical presentation may include back pain, discomfort, neurological abnormalities, as well as other clinical signs like temperature, malaise, and loss of weight. The multidisciplinary therapeutic care of Pott's illness is centered on a particular medicinal therapy, on-demand surgery, and a customized rehabilitation regimen...
January 2023: Curēus
https://read.qxmd.com/read/36817719/improving-functional-outcomes-and-quality-of-life-in-an-elderly-woman-with-sarcopenia-and-spinal-tuberculosis-a-case-report
#35
Irma Ruslina Defi, Nur Rusyidah Hamam, Vitriana Biben, Nuzula Chafidh Al Barqi
BACKGROUND: Indonesia is the world's second-largest contributor to TB patients. According to prevalence by age, the elderly have the most diagnosed TB. In Indonesia, TB spondylitis affects approximately 5% of TB cases and is a common cause of non-traumatic spinal cord injury (NTSCI). Spinal cord injury (SCI) is a growing public health concern, particularly among the elderly, as many of its populations have sarcopenia. Due to the complete absence of voluntary muscle contraction, SCI is followed by a rapid loss of skeletal muscle mass...
2023: Front Rehabil Sci
https://read.qxmd.com/read/36778985/re-stooping-after-corrective-osteotomy-in-patients-with-ankylosing-spondylitis
#36
JOURNAL ARTICLE
Jin-Sung Park, Byeong-Jik Kang, Tae-Hwan Kim, Hyung-Seob Ahn, Ye-Soo Park
BACKGROUND: Corrective osteotomy is an effective surgery for correcting posture in patients with ankylosing spondylitis (AS). Despite satisfactory correction, some patients experience re-stooping during follow-up. However, there have been no studies on re-stooping in AS. We aimed to analyze the factors that affect re-stooping. METHODS: Fifty patients (50 cases) who underwent thoracolumbar corrective osteotomy for AS from March 2006 to April 2018 were analyzed. We defined re-stooping as global kyphosis that recurs after corrective osteotomy...
February 2023: Clinics in Orthopedic Surgery
https://read.qxmd.com/read/36733143/-a-case-of-intractable-pyogenic-spondylitis-due-to-suture-failure-and-mrsa-infection-secondary-to-surgery-for-ascending-colon-cancer
#37
JOURNAL ARTICLE
Hideaki Yokomatsu, Masatsune Shibutani, Kei Katsuragi, Zhang Xiang, Yasuhiro Fukui, Jyumpei Nagai, Kenichiro Nakai
A 79-year-old man diagnosed with ascending colon cancer underwent laparoscopic right hemicolectomy(Stage Ⅱ). Postoperatively, suture failure occurred on Day 5 and was alleviated with conservative therapy. However, on Day 23, he was diagnosed with MRSA-induced sepsis with a body temperature of 39 °C. After administration of vancomycin, his general conditions stabilized, although intermittent low-grade fever and a high C-reactive protein(CRP)level persisted. Although the source of the infection could not be easily identified, he was diagnosed with suppurative spondylitis after lumbar MRI examination on Day 43...
December 2022: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/36650451/maternal-interleukin-17-and-disease-activity-influence-pregnancy-outcomes-in-women-with-psoriatic-arthritis-and-ankylosing-spondylitis
#38
JOURNAL ARTICLE
Ehab F Girbash, Shaimaa M Abdelwahab, Rehab M Atef, Hala E Sherif, Hussein M Abdeldayem, Doaa S Atta, Ahmed M Radwan
OBJECTIVE: We aimed in this study to evaluate the impact of maternal interleukin -17A and the activity of the illness on pregnancy outcomes in Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients. METHODS: This prospective cohort research was carried out on 48 Psoriatic arthritis and ankylosing spondylitis pregnant women attending the inpatient and outpatient clinics of the Rheumatology & Rehabilitation and Obstetrics & Gynecology Departments, Faculty of Medicine, Zagazig University Hospitals in Egypt and 30 apparently healthy age- and sex-matched pregnant women between January 1,2018, and December 31, 2019...
January 17, 2023: BMC Pregnancy and Childbirth
https://read.qxmd.com/read/36638533/accuracy-of-a-computer-vision-system-for-estimating-biomechanical-measures-of-body-function-in-axial-spondyloarthropathy-patients-and-healthy-subjects
#39
JOURNAL ARTICLE
Neil J Cronin, Maedeh Mansoubi, Erin Hannink, Benjamin Waller, Helen Dawes
OBJECTIVE: Advances in computer vision make it possible to combine low-cost cameras with algorithms, enabling biomechanical measures of body function and rehabilitation programs to be performed anywhere. We evaluated a computer vision system's accuracy and concurrent validity for estimating clinically relevant biomechanical measures. DESIGN: Cross-sectional study. SETTING: Laboratory. PARTICIPANTS: Thirty-one healthy participants and 31 patients with axial spondyloarthropathy...
January 13, 2023: Clinical Rehabilitation
https://read.qxmd.com/read/36633815/comparative-efficacy-of-biologic-disease-modifying-anti-rheumatic-drugs-for-non-radiographic-axial-spondyloarthritis-a-systematic-literature-review-and-bucher-indirect-comparisons
#40
REVIEW
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
INTRODUCTION: Biologic disease-modifying anti-rheumatic drugs (bDMARDs), including certolizumab pegol (CZP), are effective treatment options for the management of non-radiographic spondyloarthritis (nr-axSpA). In the absence of head-to-head comparisons in nr-axSpA, we conducted a systematic literature review (SLR) and indirect treatment comparison (ITC) to better understand the comparative efficacy of CZP vs. other bDMARDs. METHODS: Literature searches were conducted in October 2020 in MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials in patients with nr-axSpA who had failed at least one non-steroidal anti-inflammatory drug and were treated with bDMARDs...
April 2023: Rheumatology and Therapy
keyword
keyword
169246
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.